(Q34577070)

3 August 2017

title

Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol (English)

1 reference

3 August 2017

1 reference

William O Kline

1

1 reference

3 August 2017

Frank J Panaro

series ordinal

2

1 reference

3 August 2017

Hayung Yang

series ordinal

3

1 reference

3 August 2017

Sue C Bodine

series ordinal

4

1 reference

3 August 2017

language of work or name

English

0 references

publication date

26 October 2006

1 reference

Journal of Applied Physiology

3 August 2017

published in

1 reference

3 August 2017

volume

102

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

740-747

1 reference

Effect of clenbuterol on skeletal muscle atrophy in mice induced by the glucocorticoid dexamethasone

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Beta Adrenoceptor Agonists, Clenbuterol, and Isoproterenol Retard Denervation Atrophy in Rat Gastrocnemius Muscle: Use of 3-Methylhistidine as a Marker of Myofibrillar Degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Identification of ubiquitin ligases required for skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Magnetic resonance imaging of denervation-induced muscle atrophy: effects of clenbuterol in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Isometric resistance exercise fails to counteract skeletal muscle atrophy processes during the initial stages of unloading

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Beta-adrenergic receptors and their interacting proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the beta2-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Increased association of ribosomes with myofibrils during the skeletal-muscle hypertrophy induced either by the beta-adrenoceptor agonist clenbuterol or by tenotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Beta-adrenergic agonists and hypertrophy of skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Invited Review: Role of insulin in translational control of protein synthesis in skeletal muscle by amino acids or exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Effects of clenbuterol and propranolol on muscle mass. Evidence that clenbuterol stimulates muscle beta-adrenoceptors to induce hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Overview of the effects of beta-adrenergic receptor agonists on animal growth including mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Molecular determinants of skeletal muscle mass: getting the "AKT" together

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

The cardiac beta2-adrenergic signalling a new role for the cPLA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Control of the size of the human muscle mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Molecular and cellular determinants of skeletal muscle atrophy and hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Elevated IGF-II mRNA and phosphorylation of 4E-BP1 and p70(S6k) in muscle showing clenbuterol-induced anabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Muscle-specific effects of hindlimb suspension and clenbuterol in mature male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJAPPLPHYSIOL.00873.2006

10.1152/JAPPLPHYSIOL.00873.2006

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference